ETNB Live signals | Maximize Profits with Getagraph.com

BUY 125175 min ago

@ $9.72

Issued: 14 Feb 2024 @ 14:51

Return: -10.39%

Previous signal: Feb 14 - 10:22

Previous signal: Sell

Return: 7.40 %

Live Chart Being Loaded With Signals

Commentary (10 May 2024 @ 16:00):

89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases...

Stats
Today's Volume	708 939
Average Volume	1.13M
Market Cap	814.40M
EPS	$0 ( 2024-05-02 )
Next earnings date	( $0 ) 2024-08-07
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-4.36
ATR14	$0.0170 (0.20%)

Insider Trading

Date	Person	Action	Amount	type
2024-05-02	Babler Martin	Buy	67 700	Stock Option (Right to Buy)
2024-04-13	Babler Martin	Buy	0
2024-04-11	Ra Capital Management, L.p.	Buy	1 408 450	Common Stock
2024-02-01	Ra Capital Management, L.p.	Buy	45 150	Stock Option (Right to Buy)
2023-02-09	Ra Capital Management, L.p.	Buy	27 400	Stock Option (Right to Buy)

INSIDER POWER
35.78
Last 99 transactions
Buy: 8 717 496 \| Sell: 3 336 793

Volume Correlation

Long: -0.06 (neutral)

Short: -0.52 (weak negative)

Signal:(60.221) Neutral

89Bio Inc Correlation

10 Most Positive Correlations
VIR	0.892
IVAC	0.891
LRFC	0.891
KRMD	0.889
EDTK	0.883
OCAX	0.881
ASO	0.877
GEEX	0.876
LYTS	0.875
HOFT	0.875

10 Most Negative Correlations
IMGN	-0.891
NKTX	-0.886
HOL	-0.88
INPX	-0.877
IMPP	-0.876
CLFD	-0.875
GRNA	-0.873
BIOL	-0.873
PMVP	-0.873
SNCE	-0.871

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

89Bio Inc Correlation - Currency/Commodity

0.13
( neutral )

0.06
( neutral )

0.00
( neutral )

-0.14
( neutral )

0.33
( neutral )

-0.11
( neutral )

89Bio Inc Financials

Annual	2023
Revenue:	$0
Gross Profit:	$-273 000 (0.00 %)
EPS:	$-2.00

FY	2023
Revenue:	$0
Gross Profit:	$-273 000 (0.00 %)
EPS:	$-2.00

FY	2022
Revenue:	$0
Gross Profit:	$-240 000 (0.00 %)
EPS:	$-2.93

FY	2021
Revenue:	$0.00
Gross Profit:	$0.00 (0.00 %)
EPS:	$-4.48

Financial Reports:

No articles found.

89Bio Inc

89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also intends to develop pegozafermin for the treatment of severe hypertriglyceridemia. 89bio, Inc. was incorporated in 2018 and is headquartered in San Francisco, California.